TrialFrontiers in endocrinology2025

Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial.

Fumio Otsuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.